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Intravascular stents are being used with increasing frequency in interventional neuroradiology. We present two 
cases of arterial rupture and subarachnoid hemorrhage during middle cerebral artery stenting. Extravasation of 
contrast material and massive subarachnoid hemorrhage during stenting in one case resulted in mortality. In the 
other case, overlapping stenting and balloon tamponade on the dissected vessel, however, were performed 
emergently. Thereafter, thrombotic occlusion of the middle cerebral artery was managed by intraarterial 
abciximab administration. Serial angiography showed that normal vessel patency was reestablished within 20 
min. We discuss complications of stenting for symptomatic middle cerebral artery stenosis and their rescue work. 
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Introduction 
 
Arterial stenting is a well-established technique for the 
treatment of atherosclerotic lesions of the coronary, iliac, and 
renal vasculatures7-9). Its use in the cerebral arteries has been 
largely confined to the extracranial portions of the vessels. 
Recent advances in stent technology have allowed the 
introduction of more flexible stents that may be tracked more 
easily in the intracranial vessels. These systems revolutionize 
the management of ischemic and hemorrhagic cerebrovas-
cular disease；however, several issues remain before wides-
pread application of stent technology to the intracranial 
circulation can be advocated. Of these problems, arterial 
dissections are one of most serious complications and can 
cause ischemic symptoms by acute thromboembolism or 
delayed stenosis5). In the worst case, arterial rupture may 
develop the intracranial hemorrhage and result in serious 
morbidity or mortality19).  
As experience is gained in the intracranial circulation with 
these devices, unique procedural complications and potential 
solutions are sure to occur. We report the cases of two pati-
ents with acute arterial rupture during the stenting for the 
severe stenosis of the middle cerebral artery, treated imme-
diately with balloon tamponade with placement of an additi-
onal, overlapping stent in one patient. 
 
Case Reports 
 
Case 1 
A 54-year-old man suffered from multiple episodes of 
transient left-hemiparesis and speech arrest despite treatment 
with antiplatelet medication(aspirin 100mg/day) for 15 mo-
nths. An MR angiogram suggested the diagnosis of middle 
cerebral artery(MCA) stenosis, which was subsequently co-
nfirmed by a diagnostic cerebral angiogram. At presentation, 
the patient was neurologically intact, and a baseline MR 
image of the brain revealed no definite evidence of infarction. 
Diagnostic cerebral angiography revealed a highgrade(90%), 
eccentric, focal(length<5mm), atherosclerotic stenosis of 
the right MCA(Fig. 1A). We decided to perform a sten-
tassisted angioplasty for middle cerebral artery stenosis due 
to repeated transient ischemic attacks regardless of medi-
cation. 
All procedures were performed under local anesthesia to 
monitor his neurological status during the operation. A bolus 
dose of heparin(100units/kg) was administered intravenou-
sly, to obtain an activated clotting time of approximately 300 
seconds, and a 7-French, straight, Envoy guiding catheter 
(Cordis Endovascular, Miami Lakes, FL) was placed over 
an exchange wire in the internal carotid artery, and the 
catheter was connected to a continuous heparinized saline 
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flush. A 0.014-inch microguide wire(Wizdom；Cordis Co., 
Miami, FL) was then advanced just proximal to the stenosis 
of the right MCA, crossed the lesion, and was introduced to 
the level of inferior division of the right MCA to ensure 
maximal support(Fig. 1B). Injection of contrast material 
through the catheter confirmed its intraluminal position(Fig. 
1C). Thereafter, the balloon delivery apparatus, with a 
preloaded GFX 3.5-×9-mm coronary stent(Medtronic Arte-
rial Vascular Engineering Inc., Santa Rosa, CA), was ad-
vanced over the exchange wire and positioned across the 
stenosis by use of roadmapping technique and deployed 
abruptly by inflating the balloon to 8 atm for 3 seconds. 
During inflation of balloon, the patient complained a sudden 
headache and stiff neck. Angiogram obtained immediately 
after dilatation revealed a rupture of the right MCA, mani-
fested by acute extravasation of contrast material(Fig. 1D). 
Subsequently, the patient presented with generalized tonic-
clonic seizure with mental change, controlled with 10mg 
diazepam(Valium) intravenously. The patient was intubated 
for airway maintenance and transferred to CT scan room. CT 
scan showed massive subarachnoid hemorrhage with diffuse 
distribution of contrast material(Fig. 1E). The patient was 
dead 3 days later. 
 
Case 2 
A 42-year-old woman suffered from multiple episodes of 
transient right-arm paralysis and speech arrest despite treat-
ment with antiplatelet medication(aspirin 325mg/day) for 5 
months. She had experienced headache and dizziness appro-
ximately 5 months earlier and had been found to have a 
borderline infarction in the left hemisphere in MR imaging 
and a severe stenosis of the left middle cerebral artery in MR 
angiograms. Three months later, she experienced right-arm 
weakness and verbal disturbance, but these symptoms reso-
lved in 24 hours. Two months later, she experienced the 
same weakness and speech arrest and was admitted to our 
institution. The patient recovered completely in 10 hours and 
had a normal neurologic examination. Cerebral angiography 
confirmed the presence of 90% stenosis of the left MCA 
with slow flow to the distal MCA territory(Fig. 2A). Des-
pite medical treatment, the patient experienced multiple 
episodes of right-sided motor weakness and speech arrest 
during the previous 5-month period. Therefore, the patient 
decided to undergo a stent-assisted angioplasty for severe 
stenosis of the left MCA.  
The endovascular approach was performed via a transfe-
moral route with the patients under local anesthesia. A bolus 
dose of heparin(100units/kg) was administered intravenou-
sly, to obtain an activated clotting time of approximately 300 
seconds, and a 7-French, straight, Envoy-guide catheter 
(Cordis, FL, USA) was selectively placed in the internal 
carotid artery, and the catheter was connected to a continu-
ous heparinized saline flush. A Prowler 14 microcatheter 
(Cordis, FL, USA) was then advanced coaxially over a 
0.035-inch GT wire(Terumo, Tokyo, Japan) just proximal to 
the stenosis of the left MCA. Then, 60,000 U of urokinase 
Fig. 1. Arterial rupture during stenting with GFX 3.5-×9.5-mm 
stent for the right M1 stenosis. A：Initial angiogram shows a 
high-grade(90%), eccentric, focal(length<5mm), atheroscle-
rotic stenosis of the M1 segment. B：A 0.014-inch microguide 
wire is advanced to the stenosis of the right M1 segment,
crossed the lesion, and is introduced to the level of inferior
division of the right middle cerebral artery to ensure maximal 
support. C：Angiogram confirms its intraluminal position. D：
Angiogram obtained immediately after dilatation reveals a
rupture of the right M1 segment, manifested by acute extrav-
asation of contrast material. E：CT scan demonstrates massive 
subarachnoid hemorrhage with diffuse distribution of contrast
material. 
Fig. 2. Angiograms showing a severe middle cerebral artery
stenosis treated with placement of S-660 2.5-×18-mm stent. A：
Initial angiogram shows severe stenosis of the left M1 segment.
B：Angiogram reveals the intraluminal position of a 0.014-inch
microguide wire. C：S-660 2.5-×18-mm stent (Medtronic Arterial
Vascular Engineering Inc., CA, USA) is deployed by inflating the
balloon at 6 atm for 15 seconds. D, E：After the deployment of
the stent, angiogram demonstrates remaining stenosis of the left
middle cerebral artery. F：The 2.5-mm balloon is advanced to
the stenotic portion of the distal middle cerebral artery and
further expanded. G：The 2.5-mm balloon inflates at 2 atm for
15 seconds, and subsequently deflates. H：After balloon angi-
oplasty, angiogram shows nearly restored arterial lumen. 
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was infused for 3 minutes through the microcatheter to 
reveal any evidence of acute thrombus. Posturokinase 
angiography revealed no change in the morphology of the 
lesion. The GT wire was then replaced by a 0.014-inch Hi-
Torque microguide wire(Advanced Cardiovascular System, 
CA, USA). It was then advanced just proximal to the 
stenosis of the left MCA, crossed the lesion, and was 
introduced to the level of inferior division of the left middle 
cerebral artery to ensure maximal support. Injection of 
contrast material through the catheter confirmed its intralu-
minal position(Fig. 2B). Therefore, the balloon delivery 
apparatus, with a preloaded S-660 2.5-×18-mm stent 
(Medtronic Arterial Vascular Engineering Inc., CA, USA), 
was advanced over the exchange wire and positioned across 
the stenosis by use of roadmapping technique and deployed 
by inflating the balloon at 6 atm for 15 seconds(Fig. 2C). 
Postdeployment angiography demonstrated remaining sten-
osis of the left MCA(Fig. 2D, E). Therefore, the 2.5-mm 
balloon was advanced to the stenotic portion of the distal 
MCA and further expanded(Fig. 2F). The patient underwent 
a single balloon inflation procedure at 2 atm for 15 seconds, 
followed by deflation, and two repeat of the procedure for 4 
minutes(Fig. 2G, H). At the fourth trial of balloon inflation 
with 3 atm pressure, the patient complained a sudden 
headache and stiff neck. Selective angiogram obtained im-
mediately after dilatation revealed a rupture of the left MCA, 
manifested by acute extravasation of contrast material(Fig. 
3A). The patient was treated emergently by placement of a 
second S-660 2.5-×18-mm stent(Medtronic Arterial Vas-
cular Engineering Inc., CA, USA) within the original stent. 
Second stent was overlapped with the previous stent(Fig. 3B, 
C). Subsequently the patient underwent tamponade balloon 
inflation for 3 minutes, followed by rapid deflation, and a 
repeat of the procedure after 1 minute(Fig. 3D). The size of 
the balloon chosen for tamponade was 1 mm smaller in 
diameter than the size of the balloon that caused the rupture, 
and the balloon was fully inflated without the use of a 
manometer. No extravasation was visualized, but acute 
thrombotic occlusion of the distal MCA located beyond an 
inflated balloon was encountered(Fig. 3E). In a rescue 
attempt to dissolve the intraluminal thrombus, 7mg of 
undiluted abciximab(Reopro；Centocor, Malvern, PA) was 
administered through the catheter over 5 minutes. Angiogra-
phy performed 10 minutes after the abciximab bolus showed 
partial recanalization of the left MCA thrombus(Fig. 3F). 
Additional 3mg of abciximab was administrated over a 1 
minute period. Subsequent angiography performed 20 
minutes after abciximab bolus administration showed com-
plete recanalization of the left MCA(Fig. 3G, H). There was 
no evidence of distal embolism on the intracranial angi-
ograms, and the patient had no new neurologic deficits after 
the procedure. CT scans of the head obtained immediately 
after the procedure depicted subarachnoid hemorrhage on the 
sylvian fissure. 
Full systemic heparinization was continued for 48 hours. 
Subsequently oral clopidogrel(75mg daily) and aspirin(300 
mg daily) were begun and continued for 6 weeks. Angio-
graphy performed the next day showed MCA to be normal in 
appearance. The patient underwent lumboperitoneal shunt 18 
days after the procedure due to communicating hydroce-
phalus and was discharged home 12 days after the shunt. The 
patient remained neurologically stable at the 7 months clini-
cal follow-up.  
 
Discussion 
 
The concept of using intracranial stent-assisted angio-
plasty to treat medically refractory, symptomatic, intracranial, 
vascular stenosis was based on experience with cardiac 
intervention. The use of stents for the treatment of intracrani-
al disease has previously been limited by rigid stent and stent 
delivery catheter designs that are unable to atraumatically 
maneuver acute vascular bends. Stent technology is advan-
cing at a rapid pace, with many flexible stent delivery 
systems now capable of reaching the intracranial circulation1). 
The risks of intracranial stenting for atherosclerotic disease 
Fig. 3. Angiograms showing an arterial rupture treated with
placement of an additional S-660 2.5-×18-mm stent and bal-
loon tamponade, and subsequent thrombotic occlusion tre-
ated by the intraarterial administration of abciximab. A：
Angiogram reveals an acute extravasation of contrast material.
B, C：Fluoroscopic image shows second stent is overlapped
with previous stent. D：Angiogram shows balloon tamponade
on the ruptured points. E：Angiogram shows no extravasation
of contrast material, but acute thrombotic occlusion of the
distal M1 segment located beyond an inflated balloon. F：After
the intraarterial administration of 7mg abciximab, angiogram
shows a partial recanalization of the left M1 segment. G, H：
After the additional administration of 3mg abciximab, angiog-
rams reveal complete recanalization of the left middle cerebral
artery. 
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have decreased with growing experience in the field, 
improved materials. The complications of the intracranial 
stenting include acute thrombosis, distal thromboembolism, 
arterial spasm, dissection with hemodynamic impact, gui-
dewire perforation, and arterial rupture of the dilatation site5). 
Some of these complications, such as vasospasm and dis-
section, are temporary and may result in minor neurological 
deficits. However, other complications, such as arterial rupt-
ure and acute thrombosis, are more serious and may result in 
neurologic sequelae or otherwise threaten the patient’s life19). 
Certain factors associated with arterial dissection or rup-
ture during percutaneous transluminal angioplasty or stenting 
are containing balloon size and its inflation pressure and 
velocity1,2,12,15). As our first case shown, the abrupt dilation of 
balloon and inappropriate inflation pressure has increased 
risk of vessel rupture. Balloon overdilation is not an accepted 
practice in the intracranial circulation, and it may be espe-
cially dangerous in the basilar artery and middle cerebral 
artery, where different authors advocate underdilation(no 
more than half of the normal diameter) because of the 
insubstantial muscularis and adventitial layers of the arterial 
wall and the subsequent elevated risk of perforation. In 
addition, constrained balloons have markedly higher internal 
pressure, which may lead to vessel rupture if balloons are 
much larger than the vessel diameter16). Therefore, it is 
desirable that smaller size of balloon than diameter of vessel 
should be gradually dilated with lower pressure than nominal 
pressure1,13).  
No firm data exist concerning the risk of the intracranial 
stenting as related to lesion location. In several series, there 
was no clear statistical result of which lesions are safer or of 
which are more dangerous. We found an 8.3% per-patient 
intracranial arterial complication rate during percutaneous 
revascularization procedures performed over a 3-year period, 
including a 3.3% rupture rate, an unpublished data. It appe-
ars that the primary risk is operator-dependent, followed 
closely by the risks related to location and type of lesion5). 
Typical intracranial atherosclerotic disease presents in prima-
rily five locations: the ICA carotid siphon, the main trunk of 
the middle cerebral artery, the distal vertebral artery, the 
vertebrobasilar junction, and the midportion of the basilar 
artery5). The middle cerebral artery has a highest risk of the 
rupture or dissection in our series. In case 1, the patient died 
as a result of massive subarachnoid hemorrhage, although 
emergent balloon occlusion was achieved. We learned se-
veral valuable lessons from these complications we observed. 
Traditionally, the definitive treatment for traumatic intrac-
ranial artery rupture or pseudoaneurysm has been surgical 
repair4). This treatment itself, however, is associated with an 
unacceptable incidence of major complications, such as 
death and major stroke, and it is often an ineffective or even 
harmful treatment. In experience in peripheral circulation, 
the immediate treatment for acute iatrogenic rupture is 
balloon tamponade11). If failed of the initial balloon tam-
ponade, placement of an additional stent may be effective 
because stent placement has been used effectively in the past 
to treat iatrogenic or traumatic rupture of the peripheral 
arteries6,14). Another patient was treated with still another 
ancillary technique, the placement of a stent-graft10), after the 
initial tamponade procedure was not successful. Conceivably, 
a commercially manufactured stent-graft would be more 
readily available and easier to deploy3). In conclusion, as our 
case has shown, patency can be quickly reestablished in 
acute rupture with additional stenting and balloon tamponade, 
even in the occurrence of thrombus. 
Acute thrombosis is a potential complication of arterial 
angioplasty and stent placement. Because acute thrombosis 
is known to be platelet-rich thrombus, we elected to admi-
nister a platelet glycoprotein Ⅱb/Ⅲa antagonist as a rescue 
attempt to dissolve the clot. The potential mechanisms of this 
thrombolytic effect include active platelet deaggregation at 
the site of thrombus, endogenous autothrombolysis, and 
inhibition of platelet-rick thrombus propagation18). Reports 
of the use of abciximab for neurovascular applications 
include its use as an adjunct to vertebrobasilar and carotid 
angioplasty, prevention of basilar artery rethrombosis after 
PTA, and rescue in acute carotid stent thrombosis17). To our 
knowledge, this is the first report documenting abciximab 
use during an intracranial stenting procedure as successful 
rescue of thrombotic occlusion of the middle cerebral artery. 
 
Conclusion 
 
We describe two cases in which stenting of the MCA were 
complicated by acute rupture and thrombosis. One case was 
successfully controlled by endovascular treatment 3/4 an 
endovascular rescue not previously mentioned in the litera-
ture. Smaller size of balloon than diameter of vessel should 
be gradually dilated with lower pressure than nominal 
pressure for the prevention of intraprocedural rupture. If 
ruptured, urgent diagnosis and treatment of an iatrogenic 
injury of the intracranial artery is essential, as any delay may 
result in the patient’s death. If acute extravasation of contrast 
material is encountered, balloon tamponade with an addi-
tional stenting is the immediate step that can be taken. 
Additionally, the intraarterial use of abciximab may be 
feasible and safe and it offers successful recanalization of 
acute thrombotic occlusions during the stenting. 
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